The DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index.
Adipose Mesenchymal Extracellular Vesicles as Alpha-1-Antitrypsin Physiological Delivery Systems for Lung Regeneration
Open accessAbstract
Accumulating evidence shows that Mesenchymal Stem/Stromal Cells (MSCs) exert their therapeutic effects by the release of secretome, made of both soluble proteins and nano/microstructured extracellular vesicles (EVs). In this work, for the first time, we proved by a proteomic investigation that adipose-derived (AD)-MSC-secretome contains alpha-1-antitrypsin (AAT), the main elastase inhibitor in the lung, 72 other proteins involved in protease/antiprotease balance, and 46 proteins involved in the response to bacteria. By secretome fractionation, we proved that AAT is present both in the soluble fraction of secretome and aggregated and/or adsorbed on the surface of EVs, that can act as natural carriers promoting AAT in vivo stability and activity. To modulate secretome composition, AD-MSCs were cultured in different stimulating conditions, such as serum starvation or chemicals (IL-1β and/or dexamethasone) and the expression of the gene encoding for AAT was increased. By testing in vitro the anti-elastase activity of MSC-secretome, a dose-dependent effect was observed; chemical stimulation of AD-MSCs did not increase their secretome anti-elastase activity. Finally, MSC-secretome showed anti-bacterial activity on Gram-negative bacteria, especially for Klebsiella pneumoniae. These preliminary results, in addition to the already demonstrated immunomodulation, pave the way for the use of MSC-secretome in the treatment of AAT-deficiency lung diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 (A) Proteins secreted by human Adipose-Derived Mesenchymal Stem/Stromal Cells (AD-MSCs) and grouped in four functional categories including protease/peptidase activity, protease/peptidase inhibitor activity, response to bacteria, and acute-phase response (see Table S1); in addition, proteins belonging to a functional category were further split, where possible, by protein families. (B) Topological evaluation of the network (290 nodes and 3836 interactions) reconstructed by combining proteins secreted by human AD-MSCs and Homo sapiens protein-protein interaction (PPI) data [7]. Proteins in the graph showed betweenness, centroid, and degree values above the average calculated on the whole network, thus are considered hubs; the complete list (290 proteins) and the corresponding topological parameters (betweenness, centroid, and degree) are shown in Table S2. (C) Proteins secreted by human AD-MSCs experimentally identified [7] and annotated as SERPINA1 interactors.](https://figures.cochat.ai/paper-figures/61b0309610d84ecdb8398c1c035a4fef/adipose-mesenchymal-extracellular-vesicles-as-alpha-1-antitrypsin-physiological-figure-1.jpg)






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“VEGF, FGF-2, PDGF, SDF1, CXCL-1, RANTES, MCP-1 and M-CSF are factors present in the MSC secretome known for inducing angiogenesis by binding to their corresponding receptors on endothelial cells and activating the signaling pathways p38/MAPK, PI3K/AKT, MEK/ERK [94], [95], [96].”
From Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? (2025) · cites this paper as [94]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930 · cited 1×
“In fact, EVs entail several advantages as drug delivery vehicles [50]; among all, we consider their ability to protect cargo from degradation [51], stability in the blood circulation, ability to overcome natural barriers [52,53], and intrinsic cell targeting properties.”
BackgroundMaere, S., Heymans, K., & Kuiper, M. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti551 · Cited by 4,155
Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data
Doncheva, N. T., Morris, J. H., Gorodkin, J., & Jensen, L. J. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00702 · Cited by 2,306
Concise review: MSC-derived exosomes for cell-free therapy
Phinney, D. G., & Pittenger, M. F. (2017) · Stem Cells · doi:10.1002/stem.2575 · Cited by 1,834
A travel guide to Cytoscape plugins
Saito, R., Smoot, M. E., Ono, K., Ruscheinski, J., Wang, P.-L., Lotia, S., Pico, A. R., Bader, G. D., & Ideker, T. (2012) · Nature Methods · doi:10.1038/nmeth.2212 · Cited by 1,500
Zhuang, X., Xiang, X., Grizzle, W., Sun, D., Zhang, S., Axtell, R. C., Ju, S., Mu, J., Zhang, L., Steinman, L., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.164 · Cited by 1,356
Extracellular vesicles for drug delivery.
Vader, P., Mol, E. A., Pasterkamp, G., & Schiffelers, R. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.006 · Cited by 1,319
Stoller, J. K., & Aboussouan, L. S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66781-5 · Cited by 695
Research works printed but not linked: 1
- Nelson, D.L., and Cox, M.M. (2017). Lehninger Principles of Biochemistry, Springer.
Cited by
Harrell, C. R., Jovicic, N., Djonov, V., Arsenijevic, N., & Volarevic, V. (2019) · Cells · doi:10.3390/cells8121605 · Cited by 795
Maumus, M., Rozier, P., Boulestreau, J., Jorgensen, C., & Noël, D. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00997 · Cited by 203
Moghadasi, S., Elveny, M., Rahman, H. S., Suksatan, W., Jalil, A. T., Abdelbasset, W. K., Yumashev, A. V., Shariatzadeh, S., Motavalli, R., Behzad, F., et al. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02980-6 · Cited by 203
RetractedMesenchymal stem cell secretome for regenerative medicine: Where do we stand?
Trigo, C. M., Rodrigues, J. S., Camões, S. P., Solá, S., & Miranda, J. P. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2024.05.004 · Cited by 252
“VEGF, FGF-2, PDGF, SDF1, CXCL-1, RANTES, MCP-1 and M-CSF are factors present in the MSC secretome known for inducing angiogenesis by binding to their corresponding receptors on endothelial cells and activating the signaling pathways p38/MAPK, PI3K/AKT, MEK/ERK [94–96].”
Li, L., Ngo, H. T. T., Hwang, E., Wei, X., Liu, Y., Liu, J., & Yi, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010049 · Cited by 126
Metadata
- Authors
- Bari, E., Ferrarotti, I., Di Silvestre, D., Grisoli, P., Barzon, V., Balderacchi, A., Torre, M. L., Rossi, R., Mauri, P., Corsico, A. G., & Perteghella, S.
- Affiliations
- University of Pavia (IT)
- Institute for Biomedical Technologies, F.lli Cervi 93, 20090 Segrate, Milan, Italy
- Institute of Biomedical Technologies (IT)
- Corresponding author
- Torre, Maria Luisa
- ORCID
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2019-08-23
- Volume
- 8
- Issue
- 9
- Pages
- 965
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC6770759
- OpenAlex
- W2969490899
- Cited by
- 70
- References
- 69
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 10 · 2023: 4 · 2022: 8 · 2021: 24 · 2020: 12 · 2019: 2
- FWCI
- 3.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Regione Lombardia (637541)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- adipose-derived mesenchymal stromal cells, extracellular vesicles, alpha-1-antitrypsin, secretome, lung regeneration, protease-antiprotease balance, anti-elastase activity, antibacterial activity, Klebsiella pneumoniae, serum deprivation, IL-1β, dexamethasone
- MeSH terms
- Extracellular Vesicles, Adult, alpha 1-Antitrypsin, Cells, Cultured, Dexamethasone, Female, Humans, Lung, Middle Aged, Regeneration, Up-Regulation, Adipocytes, Proteomics, Interleukin-1beta, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adipose Mesenchymal Extracellular Vesicles as Alpha-1-Antitrypsin Physiological Delivery Systems for Lung Regeneration. https://app.cochat.ai/papers/10.3390/cells8090965
- The paper
- Bari, E., Ferrarotti, I., Di Silvestre, D., Grisoli, P., Barzon, V., Balderacchi, A., Torre, M. L., Rossi, R., Mauri, P., Corsico, A. G., & Perteghella, S. (2019). Adipose Mesenchymal Extracellular Vesicles as Alpha-1-Antitrypsin Physiological Delivery Systems for Lung Regeneration. Cells. https://doi.org/10.3390/cells8090965
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.